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Abstract
Background: We examined the relationship between the intima-media thickness of the common carotid artery
(CCA-IMT) and arterial stiffness, assessed by pulse wave velocity (PWV), the ambulatory arterial stiffness index (AASI)
and the augmentation index (AIx) in subjects with and without type 2 diabetes.
Methods: A case-series study was made in 366 patients (105 diabetics and 261-non-diabetics). Ambulatory blood
pressure monitoring was performed on a day of standard activity with the SpaceLabs 90207 system. AASI was
calculated as “1-slope” from the within-person regression of diastolic-on-systolic ambulatory blood pressure
readings. PWV and AIx were measured with the SphygmoCor system, and a Sonosite Micromax ultrasound unit
was used for automatic measurements of CCA-IMT.
Results: PWV, AASI and CCA-IMT were found to be greater in diabetic patients, while no differences in AIx were
observed between the two groups. CCA-IMT was independently correlated to the three measures of arterial
stiffness in both groups. We found an increase in CCA-IMT of 0.40, 0.24 and 0.36 mm in diabetics, and of 0.48, 0.17
and 0.55 mm in non-diabetics for each unit increase in AASI, AIx and PWV. The variability of CCA-IMT was
explained mainly by AASI, AIx and gender in diabetic patients, and by age, gender, AASI and PWV in non-diabetic
patients.
Conclusions: CCA-IMT showed a positive correlation to PWV, AASI and AIx in subjects with and without type 2
diabetes. However, when adjusting for age, gender and heart rate, the association to PWV was lost in diabetic
patients, in the same way as the association to Alx in non-diabetic patients. The present study demonstrates that
the three measures taken to assess arterial stiffness in clinical practice are not interchangeable, nor do they behave
equally in all subjects.
Introduction
The ultrasound measurement of the intima-media thick-
ness of the common carotid artery (CCA-IMT) has been
recognized as a powerful method for identifying subcli-
nical atherosclerosis. CCA-IMT is well-known to be a
strong predictor of future vascular events and a surro-
gate marker of atherosclerosis [1-3].
Arterial stiffness assessed through pulse wave velocity
(PWV) [4,5] and the ambulatory arterial stiffness index
(AASI) [6,7]) is regarded as an independent predictor of
cardiovascular mortality and morbidity in patients with
cardiovascular disease as well as in healthy individuals.
However, the data on the central Augmentation index
(AIx) are contradictory [8] and its role in the clinical
setting remains unclear. Several studies suggest that the
methods would not be interchangeable in a clinical
setting [9-12].
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and AASI in untreated hypertensive patients [13]. The
studies made in type 2 diabetic patients conclude that
PWV is associated to microalbuminuria [14] and renal
function estimated by the glomerular filtration rate [15].
However, there are no data on the relationship between
IMT and arterial stiffness at central level. A recent
study in a Japanese population with type 2 diabetes
f o u n dC C A - I M T ,b u tn o tP W V ,t ob ei n d e p e n d e n t l y
associated to silent cerebral infarction [3].
The present study examines the relationship between
CCA-IMT and arterial stiffness evaluated by PWV,
AASI and AIx in subjects with and without type 2
diabetes.
Materials and methods
Study design and population: A case-series study was
conducted in a primary care setting. Using consecutive
sampling, we included 366 patients (105 diabetics and
261 non-diabetics) from a population of 46,000 people
corresponding to two primary care centers. The patients
were between 30-80 years old, visited their family doctor
between January 2.009 and June 2.010, and signed the
informed consent to participation in the study. The lat-
ter adhered to the principles of the Declaration of Hel-
sinki, and was approved by an independent ethics
committee of Salamanca University Hospital (Spain).
Measurement
A detailed description of the measurement techniques
can be found elsewhere [16]. Clinical blood pressure
was determined by performing three systolic blood pres-
sure (SBP) and diastolic blood pressure (DBP) measure-
ments with a validated sphygmomanometer (OMRON
M7, Omron Health Care, Kyoto, Japan), following the
recommendations of the European Society of Hyperten-
sion [17]. The mean of the last two measurements
obtained by the nurse of the research unit was used for
the study.
Ambulatory blood pressure monitoring (ABPM) was
performed on a day of standard activity, using a cuff sui-
ted to the size of the patient’s arm. A SpaceLabs 90207
control system (Spacelabs Healthcare, Issaquah,
Washington, USA), validated according to the protocol
of the British Hypertension Society, was used [18]. The
records of readings considered to be valid were ≥ 66%
of the total. Furthermore, in order for the records to be
evaluable, at least 14 measurements were required dur-
ing the daytime period, or at least 7 during the night-
time or rest period. The monitor was programmed to
obtain blood pressure recordings every 20 min. during
the daytime period and every 30 min. during the rest
period.
Ambulatory arterial stiffness index
AASI was calculated as 1 minus the regression slope of
diastolic blood pressure (DBP) plotted against systolic
blood pressure (SBP) obtained through individual 24-
hour blood pressure monitoring [19]. The stiffer the
arterial tree, the closer the regression slope and AASI
are to 0 and 1, respectively [20,21].
Pulse wave analysis (PWA) and pulse wave velocity (PWV)
AIx and PWV were estimated using the SphymgoCor
System (AtCor Medical Pty Ltd Head Office, West
Ryde, Australia), currently accepted as the gold standard
for measuring arterial stiffness. Using the SphygmoCor
System (Px Pulse Wave Analysis), with the patient in
the sitting position and resting the arm on a rigid sur-
face, pulse wave analysis was performed with a sensor in
the radial artery, using mathematical transformation to
estimate the aortic pulse wave. From the morphology of
the aortic wave, central (aortic) blood pressure, the pres-
sure increase, and central pressure pulse were estimated.
Central AIx was estimated using the following formula:
increase in central pressure * 100/pulse pressure. Using
the SphygmoCor System (Vx Pulse Wave Velocity), and
with the patient in the supine position, the pulse wave
of the carotid and femoral arteries was analyzed,
estimating the delay with respect to the ECG wave and
calculating the PWV. Distance measurements were
taken with a measuring tape from the sternal notch to
the carotid and femoral arteries at the sensor location
[16]. A measurement of greater than 12 m/s was consid-
ered to indicate subclinical organ damage (SOD) [22].
Assessment of carotid intima-media thickness (IMT)
Carotid ultrasound for assessing IMT was performed by
two investigators specifically trained to the effect before
starting the study. The reliability of the measurements
was evaluated before the start of the study using the
intraclass correlation coefficient, which showed values of
0.97 for intraobserver agreement on repeated measure-
ments in 20 subjects, and 0.89 for interobserver agree-
ment. A Sonosite Micromax ultrasound device coupled
to a 5-10 MHz multifrequency high-resolution linear
transducer with Sonocal software was used for perform-
ing automatic measurements of IMT in order to opti-
mize reproducibility. Measurements were made of the
common carotid after the examination of a 10-mm
longitudinal section at a distance of 1 cm from the
bifurcation, performing measurements in the anterior or
proximal wall, and in the posterior or distal wall in the
lateral, anterior and posterior projections, following an
axis perpendicular to the artery to discriminate two
lines: one for the intima-blood interface and the
other to the media-adventitious interface. A total of
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Page 2 of 86 measurements were obtained of the right carotid and
another 6 of the left carotid, using average values (aver-
age IMT) and maximum values (maximum IMT) calcu-
lated automatically by the software. The measurements
were obtained with the subject lying down, with the
head extended and slightly turned opposite to the exam-
ined carotid, following the recommendations of the
Manheim Carotid Intima-Media Thickness Consensus
[23]. Mean IMT was considered to be abnormal if above
0.9 mm, or if there were atherosclerotic plaques with a
diameter of over 1.5 mm, or a focal increase of 0.5 mm,
or 50% of the adjacent IMT [22].
Statistical analysis
Continuous variables were expressed as the mean ±
standard deviation, while frequency distributions were
used in application to qualitative variables. The mean
difference between two categories of qualitative variables
was analyzed with the Student’s t-test for independent
samples. Pearson’s correlation coefficient was used to
estimate the relationship between the quantitative
variables, while the chi-square test was used to associate
the qualitative variables. We performed multiple linear
regression analysis by means of the enter method, using
CCA-IMT as dependent variable -and parameters such
as age, gender (male = 1; female = 0), office heart rate,
AASI, AIx and PWV as independent variables. In order
to obtain a homogeneous measurement scale and facili-
tate interpretation of the regression analysis, standar-
dized variables were used. The data were analyzed using
the SPSS version 17.0 statistical package (SPSS Inc., Chi-
cago, Illinois, USA). A value of P < 0.05 was considered
statistically significant.
Results
The main clinical characteristics of the patients
(105 diabetics and 261 non-diabetics) are reported in
Table 1. AASI, PWV, CCA-IMT and the percentage of
patients presenting subclinical organ damage (SOD) in
carotid arteries were higher in diabetic patients, though
no differences in AIx were observed between the two
groups.
Table 1 General demographic and clinics characteristics: in subjects with and without type 2 diabetes
Age* 55.07 ± 11.92 59.81 ± 10.20 53.32 ± 12.05
Male, n (%) Female, n (%) 220 (61.08) 136 (38.20) 65 (67.70) 31 (32.30) 155 (59.60) 105 (40.40)
Smokers, n (%) 84 (23.60) 20 (20.80) 64 (24.60)
Ischemic heart disease, n (%)* 25 (7.00) 15 (15.60) 10 (3.80)
Cerebrovascular disease, n (%) 6 (1.70) 2 (2.10) 4 (1.50)
Body mass index, kg/m2* 28.48 ± 4.35 29.97 ± 5.24 27.93 ± 3.84
Waist circumference, (cm)* 97.52 ± 11.97 102.58 ± 12.51 95.66 ± 11.23
Total Cholesterol, (mg/dl)* 203.55 ± 37.05 188.00 ± 33.26 209.33 ± 36.77
Tryglicerides, (mg/dl) 131.10 ± 77.10 143.11 ± 86.09 126.63 ± 73.16
LDL cholesterol, (mg/dl)* 125.24 ± 32.63 109.94 ± 26.53 130.92 ± 32.89
HDL cholesterol,(mg/dl)* 51.96 ± 12.58 48.32 ± 10.75 53.32 ± 12.96
Serum glucose, (mg/dl)* 99.54 ± 30.00 132.00 ± 39.79 87.51 ± 10.71
Serum creatinine, (mg/dl) 0.88 ± 0.18 0.85 ± 0.15 0.89 ± 0.18
Office SBP, mm Hg 139.26 ± 17.24 137.56 ± 18.43 139.89 ± 16.77
Office DBP, mm Hg* 86.88 ± 10.03 83.03 ± 11.22 88.31 ± 10.64
Office PP, mm Hg 52.95 ± 13.10 55.11 ± 13.63 52.16 ± 12.84
HR office bpm 72.26 ± 12.75 72.10 ± 12.97 72.37 ± 12.69
24-hour SBP, mm Hg* 125.79 ± 12.80 123.43 ± 12.60 126.66 ± 12.79
24-hour DBP, mm Hg* 77.01 ± 9.88 72.60 ± 8.66 78.64 ± 9.82
24-hour PP, mm Hg* 48.78 ± 9.68 50.83 ± 10.06 48.02 ± 9.45
Night/day ratio SBP 0.88 ± 0.07 0.90 ± 0.07 0.88 ± 0.08
Night/day ratio DBP* 0.83 ± 0.09 0.85 ± 0.09 0.83 ± 0.09
AASI* 0.38 ± 0.06 0.40 ± 0.06 0.37 ± 0.05
PWV, (m/s)* 9.00 ± 2.23 9.91 ± 2.34 8.68 ± 2.10
AIx 30.27 ± 11.49 30.77 ± 11.14 30.09 ± 11.63
Carotid IMT, mm* 0.73 ± 0.11 0.77 ± 0.11 0.71 ± 0.11
Carotid SOD, n (%)* 53 (14.90) 25 (26.00) 28 (10.80)
Data for qualitative variables are expressed as n (%) and quantitative variables as mean ± standard deviation. SBP: systolic blood pressure; DBP: dyastolic blood
pressure; PP: pulse pressure; HR: heart rate; bpm: beats per minute; LDL: low density lipoprotein; HDL: high density lipoprotein; AASI: ambulatory arterial stiffness
index; AIx: augmentation index; PWV: pulse wave velocity; IMT: intima-media thickness; SOD: subclinical organ damage. p:statistically differences between
subjects with type 2 diabetes and non-diabetic. *p < 0.05.
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patient age, cardiovascular risk factors and the different
measures of clinical blood pressure and blood pressure
are shown in Table 2. An increase in age, 24-hour blood
pressure monitoring and CCA-IMT were associated
with a rise in the three measurements of arterial stiff-
ness in both groups. An increase in the night/day ratio
of SBP and DBP was associated to an increase in AASI
and PWV in the two groups; however, there was no cor-
relation to AIx in either of them. Office and ambulatory
blood pressure showed a positive correlation to PWV
and AASI, though only ambulatory pressure monitoring
was correlated to AIx. The latter was not associated to
PWV in diabetic patients, or to AASI in non-diabetic
patients. However, carotid CCA-IMT showed a positive
correlation to all the arterial stiffness parameters.
Figure 1 shows the simple linear regression straight
line of CCA-IMT with the parameters that assess arter-
ial stiffness. In diabetic patients, CCA-IMT increased by
0.40, 0.24 and 0.36 mm per each unit increase in AASI,
AIx and PWV. In non-diabetic patients, CCA-IMT
increased by 0.48, 0.17 and 0.55 mm per each unit
Table 2 Univariate Pearson correlations between IMT, risk factors and arterial stiffness measures (ambulatory arterial
stiffness index, augmentation index and pulse wave velocity) in subjects with and without type 2 diabetes
Ambulatory arterial stiffness index Augmentation index Pulse wave velocity Carotid IMT, mm
Univariate Correlation coefficient Correlation coefficient Correlation coefficient Correlation coefficient
Diabetics
Age 0.45** 0.30** 0.48** 0.41**
Body mass index, kg/m
2 0.08 -0.08 0.20 0.04
Waist circumference, (cm) 0.13 -0.13 0.30** 0.21*
Total Cholesterol, (mg/dl) -0.09 -0.02 0.09 0.04
Tryglicerides, (mg/dl) -0.14 -0.03 0.11 -0.02
LDL cholesterol, (mg/dl) -0.14 -0.05 -0.02 0.09
HDL cholesterol, (mg/dl) 0.17 0.16 0.08 -0.13
Office PP, mm Hg 0.65** 0.03 0.52** 0.36**
HR office bpm -0.24 -0.44** 0.09 -0.14
24-hour PP, mm Hg 0.87** 0.25* 0.44** 0.37**
Night/day ratio SBP 0.33** 0.11 0.19 0.03
Night/day ratio DBP 0.39** 0.05 0.22* 0.05
Carotid IMT, mm 0.35** 0.22* 0.36** 1
AASI 1 0.24* 0.41** 0.35**
AIx 0.24* 1 0.08 0.22*
PWV m/s 0.41** 0.08 1 0.36**
No Diabetics
Age 0.43** 0.38** 056** 0.67**
Body mass index, kg/m
2 0.08 -0.17** 0.17** 0.12
Waist circumference, (cm) 0.01 -0.21** 0.22** 0.20**
Total Cholesterol, (mg/dl) -0.04 0.09 0.08 0.10
Tryglicerides, (mg/dl) -0.10 -0.08 0.06 0.04
LDL cholesterol, (mg/dl) -0.04 0.05 0.10 0.10
HDL cholesterol, (mg/dl) 0.08 0.22** -0.07 -0.06
Office PP, mm Hg 0.58** 0.11 0.32** 0.38**
HR office bpm -0.19** -0.25** 0.05 -0.17**
24-hour PP, mm Hg 0.85** 0.14* 0.34** 0.43**
Night/day ratio SBP 0.27** 0.13* 0.19** 0.30**
Night/day ratio DBP 0.27** 0.13* 0.17** 0.23**
Carotid IMT, mm 0.42** 0.17** 0.49** 1
AASI 1 0.09 0.30** 0.42**
AIx 0.09 1 0.23** 0.17**
PWV m/s 0.30** 0.23** 1 0.50**
LDL: low density lipoprotein; HDL: high density lipoprotein; MBP: mean blood pressure; PP: pulse pressure; SBP: syistolic blood pressure; DBP: dyastolic blood
pressure; HR: heart rate; bpm: beats per minute; IMT: intima-media thickness. AASI: ambulatory arterial stiffness index; AIx: augmentation index; PWV: pulse wave
velocity. *p: p < 0.05.**p < 0.01.
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Page 4 of 8increase in AASI, AIx and PWV. However, diabetic
patients were derived from more elevated values of
CCA-IMT. The variability of CCA-IMT in diabetic
patients was mainly explained by AASI, AIx and gender;
age, PWV and heart rate were not significant. However,
in non-diabetic subjects CCA-IMT variability was
explained by age, gender, AASI and PWV, and only AIx
and heart rate had no significant influence (Table 3).
Discussion
T h ep r e s e n ts t u d yp r o v i d e st h ef i r s ts y s t e m a t i ce v a l u a -
tion of the relationship between CCA-IMT and arterial
stiffness in subjects with type 2 diabetes and in non-
diabetics. We found that the values of AASI, PWV and
CCA-IMT, but not AIx, are higher in diabetic subjects.
There is a positive correlation between CCA-IMT and
the parameters used to assess arterial stiffness. However,
AASI would explain the variability of CCA-IMT in both
groups, AIx only in diabetic patients, and PWV in non-
diabetic subjects.
In the same way as in patients with metabolic syn-
drome, where according to the CARMELA study [24]
CCA-IMT increases with the number of existing risk
factors, patients with type 2 diabetes show higher CCA-
IMT values.
As in other studies which compare subjects with and
without type 2 diabetes [25], patients with or without
renal disease [9] and healthy people versus hypertensive
patients [11], we found no differences in AIx between
subjects with and without type 2 diabetes. These results
support the conclusion of Lacy et al. [25] who found
PWV to be increased in people with diabetes, but this
No Diabetics
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Figure 1 Simple linear regression between intima-media thickness of the common carotid artery and arterial stiffness parameters:
pulse wave velocity (PWV), the ambulatory arterial stiffness index (AASI) and the augmentation index (AIx), in subjects with and
without type 2 diabetes. Parallel lines reflect the regression line of the relationship with 95% confidence intervals.
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Page 5 of 8was not associated to increased AIx. These findings con-
clusively demonstrate that AIx is not a reliable measure
of arterial stiffness in people with diabetes. This is very
likely to also apply to other population groups, such as
individuals with hypertension and renal disease.
In our univariate analysis AIx was not associated to
PWV (r = 0.08, p = 0.46) in diabetic patients, or to
AASI (r = 0.09, p = 0.14) in non-diabetic patients. Li
et al. [19] reported a correlation between AIx and AASI
of r = 0.48 and between PWV and AASI of r = 0.51.
These values are higher than those found in our study,
b u ti tm u s tb er e m e m b e r e dt h a tt h es t u d yp o p u l a t i o n s
are different, and the behavior of the parameters used to
assess arterial stiffness might not be the same. The three
parameters present a positive correlation to age in both
groups, a fact already described in other studies [11,26].
The association between AASI and increased CCA-
IMT is an ongoing finding in hypertensive patients [13];
in this context, the coefficient reported by Leoncini
et al. [27] was (r = 0.20), which is lower than the value
described by Garcia et al. [28] (r = 0.42), and higher
than the coefficient found in our study both in diabetics
(r = 0.31) and in non-diabetics (r = 0.20). PWV in turn
is associated to CCA-IMT in hypertensive patients [13],
whereas in diabetic patients Ito et al. [29] found a corre-
lation (r = 0.22) higher than that obtained in our study
(r = 0.15) in this group of patients.
The correlation between AIx and CCA-IMT reported
by Westerbacka et al. [30] in diabetics (r = 0.16; p <
0.01) was lower than that recorded in our study in type
2 diabetics (r = 0.20) and in non-diabetics (r = 0.17).
However, in the multiple regression analysis, on adjust-
ing for age, gender and heart rate, the AIx beta value
lost statistical significance in the group of patients with-
out diabetes. This supports the idea that AIx as a mea-
sure of arterial stiffness does not behave in the same
way in subjects with and without type 2 diabetes.
In a recently published study among untreated hyper-
tensive patients, Triantafyllidi [13] assessed the relation-
ship between the arterial stiffness values and PWV and
AASI and the presence of target organ damage. On
examining CCA-IMT, it was concluded that the simulta-
neous estimation of three noninvasive indexes of arterial
stiffness (PWV, AASI and office pulse pressure) gener-
ates valuable information regarding their association
with SOD in never-treated hypertensive patients in
reference to their dipping status.
In a study carried out by Polak et al. [31] to analyze
the influence of the different cardiovascular risk factors
upon IMT, patient age and gender were found to
account for 23.5% of the variability of CCA-IMT the
next most important factor being systolic blood
pressure.
Baumann et al. [32], in patients with normal blood
glucose levels, found carboxymethyl lysine to be asso-
ciated to an increased carotid artery diameter mainly in
hypertensive patients, but no correlation to other arterial
stiffness parameters was observed.
Table 3 Multiple Linear Regression Analysis: Relationship Between Carotid IMT and Selected Variables: in subjects
with and without type 2 diabetes
Variable Not standardized b Confidence interval 95% P
Diabetics
Dependent variable: Carotid IMT (Adjusted R
2 = 0.266)
Constante -0.43 -0.86 a -0.01 0.05
Age 0.28 -0.01 a 0.56 0.06
Gender 0.80 0.28 a 1.33 p < 0.01
HR office mpb 0.16 -0.12 a 0.43 0.26
PWV 0.11 -0.12 a 0.33 0.36
AASI 0.31 0.05 a 0.57 0.02
Augmentation index 0.29 0.02 a 0.55 0.03
No Diabetics
Dependent variable: Carotid IMT (Adjusted R
2 = 0.520)
Constante -0.34 -0.50 a -0.18 p < 0.01
Age 0.55 0.43 a 0.68 p < 0.01
Gender 0.46 0.25 a 0.68 p < 0.01
HR office mpb -0.04 -0.14 a 0.06 0.44
PWV 0.17 0.05 a 0.29 p < 0.01
AASI 0.20 0.08 a 0.31 p < 0.01
Augmentation index -0.01 -0.19a 0.11 0.91
Dependent variable: Carotic IMT: Carotic Intima-media thickness. Independent variables: Age; Gender: (male = 1; female = 0); HR: Heart rate; mbp: beats per
minute AASI: Ambulatory arterial stiffness index; PWV: pulse wave velocity. R2: determination coefficient; p: statistically significant differences (p < 0.05).
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study, which hinders longitudinal analysis between
CCA-IMT and AASI, PWV and AIx. Another restriction
is the selection of the study population, based on conse-
cutive sampling with pragmatic and broad inclusion cri-
teria. Therefore, in the analyzed population we find
diabetic and non-diabetic subjects with different treat-
ment and evolution times. These facts may limit the
external validity of the study. However, it must be
remembered that the study sample represents the gen-
eral population seen in primary care centers.
CCA-IMT showed a positive correlation to PWV,
AASI and AIx in subjects with type 2 diabetes and in
non-diabetics. However, on adjusting for gender, age
and heart rate, the association with PWV and AIx was
lost in diabetic patients and in non-diabetics, respec-
tively. The present study demonstrated that in these
patients there is poor agreement between AASI, PWV
a n dA I x ,c o n f i r m i n gt h a tt h et h r e em e a s u r e m e n t su s e d
to assess arterial stiffness in clinical practice are not
interchangeable, nor do they behave equally in all
subjects.
Lastly, we consider that follow-up studies are neces-
sary to establish the relationship between CCA-IMT and
each of these three measures, and to determine whether
their joint determination offers additional benefits.
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